Venus Remedies Ltd Locks at Upper Circuit With 3.8% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the BE series, hit its upper circuit at Rs 1,790, representing a 3.8% gain within a 5% price band. This ceiling price effectively froze trading, as the demand outstripped supply at this level. The total traded volume was 29,491 shares, with a turnover of ₹5.32 crore. The narrow intraday range of Rs 12.9, between Rs 1,776 and Rs 1,795, indicates that the stock spent most of the session near the circuit price, a typical pattern when the upper circuit is hit. The exchange's price band mechanism capped the rally, but the queue of buyers waiting to transact at this price remains unfilled — what does the full demand picture look like for Venus Remedies Ltd once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Delivery volumes provide the clearest insight into the quality of a circuit move. On 13 Aug 2026, the delivery volume surged to 12,590 shares, a remarkable 246.7% increase over the 5-day average delivery volume. This sharp rise in delivery suggests that the shares traded were largely taken into investors' demat accounts, signalling genuine buying conviction rather than intraday speculative activity. While the total traded volume on a circuit day is often mechanically suppressed due to the price lock, the rising delivery volume here is a strong positive indicator — is Venus Remedies Ltd's 3.8% surge backed by improving fundamentals or is this a liquidity-driven micro-cap move? — the data points to the former, but liquidity considerations remain important.

Moving Averages and Trend Context

Venus Remedies Ltd is trading comfortably above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a sustained bullish trend that preceded the circuit event. The stock’s recent four-day consecutive gains have cumulatively added 17.89% returns, reinforcing the strength of the uptrend. The circuit day’s price action, therefore, is not an isolated spike but an amplification of an already positive momentum. The narrow intraday range near the circuit price further supports the view of a controlled, trend-confirming rally rather than erratic volatility.

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately ₹2,399 crore, Venus Remedies Ltd falls within the micro-cap segment. This classification is crucial when interpreting the upper circuit event, as liquidity constraints are more pronounced in smaller-cap stocks. The stock’s liquidity profile allows for a trade size of around ₹0.24 crore based on 2% of the 5-day average traded value, indicating moderate liquidity but still limited compared to larger caps. This thin order book means that while the upper circuit signals strong buying interest, the ability to enter or exit sizeable positions without impacting the price remains challenging. Investors should be mindful of this liquidity risk when analysing the circuit move.

Intraday Price Action

The stock opened with a gap-up of 3.05%, quickly approaching the upper circuit price. The intraday high touched Rs 1,795, just above the closing circuit price of Rs 1,790. The narrow trading range of Rs 12.9 throughout the session reflects the price lock mechanism at work, with the stock consolidating near the ceiling. This pattern is typical for circuit hits, where the price is unable to move beyond the upper limit despite persistent buying interest. The limited price movement within the band suggests that the rally was orderly rather than volatile, consistent with the trend confirmation from moving averages.

Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. While the micro-cap status implies a smaller scale relative to industry giants, the company’s recent performance and sector positioning provide a backdrop for the current price action. The outperformance relative to the sector, which declined by 0.46% on the same day, highlights the stock’s relative strength. However, fundamental analysis should be considered alongside technical and liquidity factors to form a comprehensive view.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 1,790 capped a 3.8% gain within a 5% price band, reflecting strong buying pressure that the market’s price mechanism could not accommodate. The surge in delivery volume by 246.7% against the 5-day average is the most compelling evidence of conviction behind the move, signalling that investors are taking long-term positions rather than engaging in speculative intraday trades. The stock’s position above all major moving averages confirms a bullish trend that the circuit day amplified. However, as a micro-cap with moderate liquidity allowing trade sizes of just ₹0.24 crore, the risk of thin order books and difficulty in executing large trades remains significant — after a 3.8% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →